Full Press Release Details
Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies Sanofi-aventis plans to increase its stake in Regeneron to approximately 19%.
REGN
Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies Sanofi-aventis plans to increase its stake in Regeneron to approximately 19%
Key Takeaway: Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies Sanofi-aventis plans to increase its stake in Regeneron to approximately 19%